Wayne A. Kradjan

517 total citations
27 papers, 378 citations indexed

About

Wayne A. Kradjan is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pharmacology. According to data from OpenAlex, Wayne A. Kradjan has authored 27 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 6 papers in Pharmacology. Recurrent topics in Wayne A. Kradjan's work include Inhalation and Respiratory Drug Delivery (7 papers), Asthma and respiratory diseases (7 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Wayne A. Kradjan is often cited by papers focused on Inhalation and Respiratory Drug Delivery (7 papers), Asthma and respiratory diseases (7 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Wayne A. Kradjan collaborates with scholars based in United States. Wayne A. Kradjan's co-authors include S. Lakshminarayan, Dale F. Kraemer, Theresa Bianco, Kent E. Opheim, John R. Horn, Larry A. Bauer, John J. Marini, James P. Kehrer, Robert S. Beardsley and Joanne M. Meyer and has published in prestigious journals such as CHEST Journal, Clinical Pharmacology & Therapeutics and The Journal of Clinical Pharmacology.

In The Last Decade

Wayne A. Kradjan

24 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wayne A. Kradjan United States 12 133 95 72 55 47 27 378
Christa M. George United States 13 57 0.4× 65 0.7× 82 1.1× 93 1.7× 67 1.4× 26 400
C. Wayne Weart United States 11 31 0.2× 58 0.6× 56 0.8× 62 1.1× 20 0.4× 28 338
Teresa P. McKaveney United States 12 35 0.3× 90 0.9× 32 0.4× 62 1.1× 111 2.4× 16 407
Jenifer Wogen United States 12 102 0.8× 121 1.3× 64 0.9× 291 5.3× 53 1.1× 28 714
Aileen B Luzier United States 11 50 0.4× 20 0.2× 41 0.6× 60 1.1× 35 0.7× 17 482
Michael Lykens United States 8 192 1.4× 122 1.3× 99 1.4× 8 0.1× 20 0.4× 13 501
Boyang Bian United States 9 42 0.3× 70 0.7× 19 0.3× 63 1.1× 35 0.7× 19 372
Eric T. Herfindal United States 11 24 0.2× 30 0.3× 112 1.6× 23 0.4× 64 1.4× 24 410
Mohammed N. Al-Arifi Saudi Arabia 13 46 0.3× 29 0.3× 87 1.2× 14 0.3× 57 1.2× 30 433
Scott V. Monte United States 13 43 0.3× 184 1.9× 137 1.9× 54 1.0× 53 1.1× 30 565

Countries citing papers authored by Wayne A. Kradjan

Since Specialization
Citations

This map shows the geographic impact of Wayne A. Kradjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne A. Kradjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne A. Kradjan more than expected).

Fields of papers citing papers by Wayne A. Kradjan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne A. Kradjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne A. Kradjan. The network helps show where Wayne A. Kradjan may publish in the future.

Co-authorship network of co-authors of Wayne A. Kradjan

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne A. Kradjan. A scholar is included among the top collaborators of Wayne A. Kradjan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne A. Kradjan. Wayne A. Kradjan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kradjan, Wayne A., et al.. (2015). Inhaled Atropine Sulfate. American Review of Respiratory Disease.
2.
Kraemer, Dale F., et al.. (2011). A Randomized Study to Assess the Impact of Pharmacist Counseling of Employer-Based Health Plan Beneficiaries With Diabetes. Journal of Pharmacy Practice. 25(2). 169–179. 37 indexed citations
3.
Kehrer, James P., et al.. (2008). New Pharmacy Faculty Enculturation to Facilitate the Integration of Pharmacy Disciplines and Faculty Retention. American Journal of Pharmaceutical Education. 72(1). 18–18. 11 indexed citations
4.
Beardsley, Robert S., Gary R. Matzke, Raylene M. Rospond, et al.. (2008). Factors Influencing the Pharmacy Faculty Workforce. American Journal of Pharmaceutical Education. 72(2). 34–34. 47 indexed citations
5.
Yamada, Tomoko, et al.. (2005). Comparison of Pharmaceutical Education Curriculums between the U.S. and Japan-Surveys Conducted at Four Universities in the U.S. and Japan for Evaluation of Recently Implemented Japanese Curriculum-. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(5). 344–354. 13 indexed citations
6.
Gibaldi, Milo & Wayne A. Kradjan. (1996). Treating Elevated Cholesterol Levels: The Great Satan in Perspective. The Journal of Clinical Pharmacology. 36(3). 189–197. 3 indexed citations
7.
Kradjan, Wayne A., et al.. (1995). Pharmacokinetics and Pharmacodynamics of Glipizide After Once‐Daily and Divided Doses. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(4). 465–471. 11 indexed citations
8.
Kradjan, Wayne A., Daniel M. Witt, Kent E. Opheim, & Francis C. Wood. (1994). Lack of Interaction Between Glipizide and Co‐Trimoxazole. The Journal of Clinical Pharmacology. 34(10). 997–1002. 3 indexed citations
9.
Meyer, Joanne M., et al.. (1993). Salmeterol: A Novel, Long-Acting Beta2-Agonist. Annals of Pharmacotherapy. 27(12). 1478–1487. 22 indexed citations
10.
Kradjan, Wayne A., et al.. (1992). Effect of Age on Bronchodilator Response. CHEST Journal. 101(6). 1545–1551. 32 indexed citations
11.
Kradjan, Wayne A., et al.. (1990). Experiential Training for Pharmacy Students in a Managed Health Care System. American Journal of Pharmaceutical Education. 54(3). 285–290. 1 indexed citations
12.
Kradjan, Wayne A., et al.. (1989). Glipizide Pharmacokinetics: Effects of Age, Diabetes, and Multiple Dosing. The Journal of Clinical Pharmacology. 29(12). 1121–1127. 28 indexed citations
13.
Kradjan, Wayne A., et al.. (1988). Single-Dose Efficacy and Safety of Zindotrine, a New Oral Bronchodilator. Drug Intelligence & Clinical Pharmacy. 22(10). 760–763. 1 indexed citations
14.
Bauer, Larry A., et al.. (1988). Glipizide pharmacokinetics in young and elderly volunteers.. PubMed. 7(3). 224–8. 18 indexed citations
15.
Horn, John R., et al.. (1987). Chlorpropamide pharmacokinetics in young healthy adults and older diabetic patients.. PubMed. 6(2). 162–4. 4 indexed citations
16.
Walker, Susannah B., Wayne A. Kradjan, & C. Warren Bierman. (1985). Bitolterol Mesylate: A Beta‐adrenergic Agent; Chemistry, Pharmacokinetics, Pharmacodynamics, Adverse Effects and Clinical Efficacy in Asthma. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 5(3). 127–137. 9 indexed citations
17.
Kradjan, Wayne A. & S. Lakshminarayan. (1985). Efficiency of Air Compressor-Driven Nebulizers. CHEST Journal. 87(4). 512–516. 51 indexed citations
18.
Kradjan, Wayne A., et al.. (1982). Effect of Hemodialysis on the Pharmacokinetics of Theophylline in Chronic Renal Failure. ˜The œNephron journals/Nephron journals. 32(1). 40–44. 9 indexed citations
19.
Kradjan, Wayne A. & S. Lakshminarayan. (1981). Allergy to aminophylline: Lack of predictability by skin testing. American Journal of Health-System Pharmacy. 38(7). 1031–1033. 4 indexed citations
20.
Kradjan, Wayne A.. (1980). In Vivo Inactivation of Gentamicin by Carbenicillin and Ticarcillin. Archives of Internal Medicine. 140(12). 1668–1668. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026